Analysts at BofA nearly doubled their price target for HIMS stock following the company’s deal with Novo. ・The firm now has a price target of $23, up from $12.5, while the rating has been upgraded to ...

March 9 (Reuters) - Hims & Hers' shares were up over 40% on Monday, after Novo Nordisk agreed to sell its blockbuster Wegovy ...

Hims & Hers stock surged over 44% in premarket trading after a report said Novo Nordisk plans to sell its obesity drugs ...

Hims & Hers stock traded more than 40% higher after the deal was announced.

Add Yahoo as a preferred source to see more of our stories on Google. Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One ...

Starting today, eligible customers can access treatment plans that include Compounded Semaglutide Pills at a special introductory offer starting at just $49 for the first month. The new Compounded ...

Hims & Hers is returning to the Super Bowl — one year after its debut spot kicked up a storm of controversy. The telehealth company announced Thursday that it will be returning to the Big Game with a ...